Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria.

Anude, Chuka J; Eze, Emeka; Onyegbutulem, Henry C; Charurat, Man; Etiebet, Mary-Ann; Ajayi, Samuel; Dakum, Patrick; Akinwande, Oluyemisi; Beyrer, Chris; Abimiku, Alash'le; Blattner, William

Anude, Chuka J; Eze, Emeka; Onyegbutulem, Henry C; Charurat, Man; Etiebet, Mary-Ann; Ajayi, Samuel; Dakum, Patrick; Akinwande, Oluyemisi; Beyrer, Chris; Abimiku, Alash'le; Blattner, William.

Affiliation

Anude CJ; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. canude@jhsph.edu

BMC Infect Dis ; 13: 113, 2013 Mar 01.

Article in En | MEDLINE | ID: mdl-23452915

Subject(s)

Anti-HIV Agents/therapeutic use; HIV Infections/drug therapy; Adult; Anemia/virology; Female; HIV Infections/immunology; HIV Infections/virology; Humans; Logistic Models; Lost to Follow-Up; Male; Middle Aged; Nigeria; Socioeconomic Factors; Treatment Outcome; Viral Load

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: BMC Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2013 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google